1. Home
  2. CYTK vs IDCC Comparison

CYTK vs IDCC Comparison

Compare CYTK & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • IDCC
  • Stock Information
  • Founded
  • CYTK 1997
  • IDCC 1972
  • Country
  • CYTK United States
  • IDCC United States
  • Employees
  • CYTK N/A
  • IDCC N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • IDCC Multi-Sector Companies
  • Sector
  • CYTK Health Care
  • IDCC Miscellaneous
  • Exchange
  • CYTK Nasdaq
  • IDCC Nasdaq
  • Market Cap
  • CYTK 5.6B
  • IDCC 5.6B
  • IPO Year
  • CYTK 2004
  • IDCC N/A
  • Fundamental
  • Price
  • CYTK $34.36
  • IDCC $221.60
  • Analyst Decision
  • CYTK Buy
  • IDCC Strong Buy
  • Analyst Count
  • CYTK 14
  • IDCC 1
  • Target Price
  • CYTK $70.92
  • IDCC $160.00
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • IDCC 247.5K
  • Earning Date
  • CYTK 08-07-2025
  • IDCC 07-31-2025
  • Dividend Yield
  • CYTK N/A
  • IDCC 1.08%
  • EPS Growth
  • CYTK N/A
  • IDCC 84.98
  • EPS
  • CYTK N/A
  • IDCC 12.66
  • Revenue
  • CYTK $19,218,000.00
  • IDCC $815,481,000.00
  • Revenue This Year
  • CYTK $34.81
  • IDCC N/A
  • Revenue Next Year
  • CYTK $643.79
  • IDCC N/A
  • P/E Ratio
  • CYTK N/A
  • IDCC $17.50
  • Revenue Growth
  • CYTK 412.21
  • IDCC 33.52
  • 52 Week Low
  • CYTK $29.31
  • IDCC $116.28
  • 52 Week High
  • CYTK $61.38
  • IDCC $237.50
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 56.37
  • IDCC 48.46
  • Support Level
  • CYTK $32.66
  • IDCC $217.75
  • Resistance Level
  • CYTK $34.34
  • IDCC $237.32
  • Average True Range (ATR)
  • CYTK 1.33
  • IDCC 5.97
  • MACD
  • CYTK 0.21
  • IDCC -1.05
  • Stochastic Oscillator
  • CYTK 76.45
  • IDCC 22.14

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.

Share on Social Networks: